Sarcoidosis: Diagnosis, Management, and Prognosis

Dear Colleagues,

Sarcoidosis, an enigmatic systemic inflammatory disorder, continues to intrigue and challenge the medical and scientific communities. As we navigate the complex landscape of this condition, characterized by an intricate interplay of genetics and environmental factors, we recognize that the broader context of epidemiology, populations, and risk factors plays a pivotal role in our quest for deeper insights.

While sarcoidosis predominantly affects the lungs and lymph nodes, its manifestations often extend their reach to various organs and tissues, including the skin, eyes, liver, heart, parotid gland, spleen, and beyond. The formation of granulomas, a hallmark of this disease, disrupts physiological harmony, presenting both diagnostic and therapeutic challenges. Recent research efforts spanning the past decade have illuminated the complex genetic–environmental interactions that trigger the immune system's response, providing invaluable insights into the pathogenesis of this condition.

In our current era of scientific advancement, we stand on the verge of transformative discoveries, thanks to the proliferation of high-throughput technologies, including single-nucleotide polymorphism (SNP) arrays, next-generation sequencing (NGS), and single-cell sequencing. These advancements and newfound affordability offer unprecedented opportunities to delve into the architecture of sarcoidosis and its diverse endophenotypes.

We are pleased to introduce our Research Topic, a platform dedicated to the exploration of big data and precision medicine in the context of sarcoidosis. Our mission is clear: to enhance the precision of sarcoidosis diagnosis, prognosis, and prediction of target organ involvement. We cordially invite contributions from clinicians and scientists who share our commitment to advancing our understanding of sarcoidosis. We particularly encourage submissions that delve into the transformative role of big data and precision medicine, with a keen focus on the impact of phenotyping, populations, risk factors, immunology, genetics, and environmental triggers. Together, we aim to redefine the boundaries of sarcoidosis research and clinical practice. Your expertise in these critical domains will enrich our understanding of the broader context surrounding sarcoidosis and contribute to a more comprehensive body of knowledge.

Dr. Natalia Rivera
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.